Unicorn Bio
Living cells underpin the fastest growing biotech sectors – from cell therapies and regenerative medicines, to cultivated meat. These industries have seen tremendous growth over the past decade. However, repurposed non-industrialized manufacturing technologies are a bottleneck for bringing affordable and scalable innovations to mass markets.
Unicorn Biotechnologies is building automated, modular cell culture manufacturing systems to make the development and manufacture of living cell based products more reliable, affordable and efficient. Unicorn Biotechnologies enables their partners to seamlessly scale their products and therapies from the lab bench to the factory floor.
Founders
Jack Reid
CEO
Jack previously worked in R&D and held commercial roles in the chemicals and biotechnology fields. He was a Fulbright fellow and holds degrees in Chemistry and Philosophy from Bates College and the University of Cambridge.
Adam Glen
CTO
Adam holds a PhD in Protein Biochemistry and has over 20 years of experience in stem cell culture and automating mammalian cell culture manufacturing processes. He has extensive R&D experience and deep expertise in commercializing cell biology and biomanufacturing products.
Milestones
Founded at Entrepreneur First
Joined the HAX accelerator part of SOSV
Seed ($3.2 million) led by Acequia Capital
Developed core platform technology/IP, first revenues, recruited core R&D team